CHGA and prostate adenocarcinoma: A widely used pan‐neuronal marker notwithstanding, TUBB3 expression was not related to neuroendocrine differentiation (NED, defined as positivity of generic NE markers chromogranin A and synaptophysin) in conventional prostate adenocarcinoma (p = 0.653).